General Information of the Compound
Compound ID |
CP0438075
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(3R,5S,8R,9S,10S,13S,14S,17E)-3-[[2,5-dimethyl-4-[2-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methyl]-17-hydroxyimino-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C33H48F3N3O4S
|
||||||||||||||||||
Molecular Weight |
639.825
|
||||||||||||||||||
Canonical SMILES |
CC1CN(C(C)CN1C[C@@]1(O)CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC\C(=N/O)[C@@]4(C)CC[C@H]23)C1)S(=O)(=O)c1ccccc1C(F)(F)F
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C33H48F3N3O4S/c1-21-19-39(44(42,43)28-8-6-5-7-27(28)33(34,35)36)22(2)18-38(21)20-32(40)16-15-30(3)23(17-32)9-10-24-25-11-12-29(37-41)31(25,4)14-13-26(24)30/h5-8,21-26,40-41H,9-20H2,1-4H3/b37-29+/t21?,22?,23-,24-,25-,26-,30-,31-,32+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
AMZTXKLGCSGHKY-PVAGVHHTSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound